David DeGoey
7PUBLICATIONS
13CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|May 14, 2025
Explainable Machine Learning for ETR and Drug Chameleonicity.Edward Price, Matthieu Dagommer, Mattson Thieme
|Mar 18, 2024
Beyond Rule of Five and PROTACs in Modern Drug Discovery: Polarity Reducers, Chameleonicity, and the Evolving Physicochemical Landscape.Edward Price, Manuel Weinheimer, Alexey Rivkin
|Oct 12, 2021
Implications of the Conformationally Flexible, Macrocyclic Structure of the First-Generation, Direct-Acting Anti-Viral Paritaprevir on Its Solid Form Complexity and Chameleonic Behavior.Ahmad Y Sheikh, Alessandra Mattei, Rajni Miglani Bhardwaj
|Aug 05, 2021
Desymmetrization of pibrentasvir for efficient prodrug synthesis.Eric A Voight, Stephen N Greszler, John Hartung
|Jun 21, 2021
Global Analysis of Models for Predicting Human Absorption: QSAR, In Vitro, and Preclinical Models.Edward Price, J Cory Kalvass, David DeGoey
|Sep 04, 2020
Prodrug Strategies to Improve the Solubility of the HCV NS5A Inhibitor Pibrentasvir (ABT-530).John T Randolph, Eric A Voight, Stephen N Greszler
Pageof 2
Frequent Collaborators
3 joint publications
Edward Price
2 joint publications
Eric A Voight
2 joint publications
Philip Cox
1 joint publications
John T Randolph
1 joint publications
Stephen N Greszler
1 joint publications
Ahmad Y Sheikh
1 joint publications
Alessandra Mattei
1 joint publications
Rajni Miglani Bhardwaj
1 joint publications
Kenneth M Engstrom
1 joint publications
Moiz Diwan
